Battle Card: Bicycle Therapeutics Sales Trigger

🚀 Battle Card: Bicycle Therapeutics

• Roger Dansey, M.D., Board Member · 🔗 LinkedIn

• This Bicycle Therapeutics sales trigger signals a ramp-up in oncology R&D and upcoming clinical milestones. → Source

• Accelerating clinical trial timelines to hit key inflection points

• Securing market access insights before pivotal readouts

• Primary: Clinical Trial Management System → Streamlined trial operations & faster enrollments

• Expansion: Market Access Analytics Platform → Optimized reimbursement strategies & pricing models

• Leverage this Bicycle Therapeutics sales trigger to position trial & market access solutions now.

• HQ: Cambridge, MA

• Employees: ≈ 120

• Rev: ≈ $10 M

• Website: bicycletherapeutics.com

🤼 Competitive Intel

• Medidata — Clinical Trial Management
• Unique edge: End-to-end eClinical suite
• Evaluated by VP Clinical Ops for integration

• Veeva Systems — Clinical Trial Management
• Unique edge: CRM + CTMS synergy
• Evaluated by Dir. Clinical Programs for ease of use

• Oracle Health Sciences — Clinical Trial Management
• Unique edge: Global regulatory compliance
• Evaluated by Head of QA for data integrity

• IQVIA — Market Access Analytics
• Unique edge: Real-world evidence & predictive insights
• Evaluated by VP Market Access for coverage strategy

• Clarivate — Market Access Analytics
• Unique edge: Comprehensive RWE platform
• Evaluated by Dir. HEOR for economic modeling

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑❑
OFFER_BRIEF   = ❑An all-in-one CTMS for streamlined trial operations❑
PROOF_METRIC  = ❑30% faster patient enrollment❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Roger
COMPANY     = Bicycle Therapeutics
DEPT        = Clinical Ops
SIZE        = 15
BOTTLENECK  = inefficient clinical trial operations
EVENT       = Board expansion
DETAIL      = new appointments of Roger Dansey and Hervé Hoppenot
PAIN        = accelerating clinical trial timelines
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250905119859&div=41152219
SIM_CO      = Seagen
WIN_METRIC  = 30% faster patient enrollment
NEXT_SIZE   = 25
EMP_EST     = ≈120
REV_EST     = ≈$10M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: 15-person Clinical Ops

Roger—noticed your Clinical Ops team is ≈ 15.

That’s when inefficient clinical trial operations slows growth.

We helped Seagen fix this with An all-in-one CTMS for streamlined trial operations.

Result: 30% faster patient enrollment.  
Quick call?

PS—next bottleneck hits ≈ 25.

DM ≤45 words, TONE:
Saw your post about new appointments of Roger Dansey and Hervé Hoppenot — accelerating clinical trial timelines.  
An all-in-one CTMS for streamlined trial operations. 30% faster patient enrollment.  
Quick chat?